Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ODC1 | P11926 | 2/20 | 0.82 |
| ▸ | HIF1AN | Q9NWT6 | 13/20 | 0.79 |
| ▸ | ACHE | P22303 | 2/20 | 0.72 |
| ▸ | BCHE | P06276 | 1/20 | 0.68 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.68 |
| ▸ | BACE1 | P56817 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31376176 | 0.91 | HIF1AN (0.87) | ODC1HIF1ANACHEBCHEPTPN1 | |
| SCHEMBL16694388 | 0.91 | HIF1AN (0.87) | ODC1HIF1ANACHEBCHEPTPN1 | |
| SCHEMBL16694389 | 0.91 | HIF1AN (0.87) | ODC1HIF1ANACHEBCHEPTPN1 | |
| SCHEMBL29499925 | 0.90 | ODC1 (1.00) | ODC1HIF1ANACHEBCHEPTPN1 | |
| SCHEMBL16865502 | 0.89 | ODC1 (0.84) | ODC1HIF1ANACHEBCHEPTPN1 | |
| SCHEMBL13534952 | 0.84 | ACHE (1.00) | ODC1HIF1ANACHEBCHEPTPN1 | |
| SCHEMBL31376270 | 0.84 | ACHE (1.00) | ODC1HIF1ANACHEBCHEPTPN1 | |
| SCHEMBL19960678 | 0.82 | PTPN1 (0.85) | ODC1HIF1ANACHEBCHEPTPN1 | |
| SCHEMBL31376190 | 0.82 | ACHE (0.78) | ODC1HIF1ANACHEBCHEPTPN1 | |
| SCHEMBL16694587 | 0.82 | HIF1AN (0.72) | ODC1HIF1ANACHEBCHEPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2871187-B1 | NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT | SNU R&DB FOUNDATION (KR) | 2017-09-20 | — | — | EP | disclosed |